In the early stage of acute infectious rhinitis which is not followed by the expressed frustration of the general state, rather sparing mode and the symptomatic treatment including washing of a nasal cavity warm normal saline solution, hot foot baths and vasoconstrictive medicines a short course: Xylomethazolinum, 0,1% spray, on 1 — 2 dose in each nostril 2 r / days no more than 10 days (adult); 0,05% spray, on 1 — 2 dose in each nostril 2 r / to days (children) or Naphazoline, 0,1% of a drop, on 1 — 2 drops in each nostril 2 — 4 r / days no more than 10 days (adult); 0,05% of a drop, on 1 — 2 drops in each nostril 2 — 4 r / to days (children) or Oxymetazoline, 0,05% of a drop, on 1 — 2 drops in each nostril 2 — 4 r / days no more than 10 days (adult); 0,025% of a drop, on 1 — 2 drops in each nostril 2 — 4 r / to days (children) At the confirmed bacterial nature of rhinitis there is reasonable a topical administration of antibacterial medicines for a period of 5 — 7 days: Mupirotsin, nasal ointment to enter into front departments of a nasal cavity 2 — 3 r / days during 5 — 7 days or Framycetinum, nasal spray, intranazalno on 1 dose in each nostril 4 — 6 r / days or Fuzafungin, a nasal aerosol, intranazalno on 4 doses in each nostril 4 r / days of 5 — 7 days For simplification of evacuation of a dense secret and crusts from a nasal cavity in addition to washings appoint mucolytic medicines. For topical intranasal administration the combined drug with mucolytic and vasoconstrictive action in the form of an aerosol which part Acetylcysteinum and tuaminogeptan is, possessing mucolytic, antiinflammatory, antioxidant and vasoconstrictive properties is effective: Acetylcysteinum / tuaminogeptana sulfate, a nasal aerosol, on 2 doses in each nostril 3 — 4 r / days With the same purpose can be used the moistening means representing cleared, the sea or mineral water disinfected and brought to concentration of normal saline solution. At treatment of recurrent and chronic rhinitis peroral or intranasal vaccines (the HP containing lysates of bacteria) which promote increase of immunity and prevention of repeated infections can be used.
In multicenter clinical trial efficiency of monotherapy fenspiridy is shown. Drug causes statistically reliable improvement of symptoms of allocation from a nose and a congestion of a nose, allowing to reach the excellent and good result of treatment at 90% of patients. Fenspirid, tablets, on 80 mg 3 r / days in 10 days; syrup, 10 — 60 ml/days in 3 receptions of 10 days (children)
Assessment of efficiency of treatment
Criterion of efficiency of treatment of infectious rhinitis is disappearance of clinical manifestations.
Complications and side effects of treatment
Complications and side effects of treatment by vasoconstrictive medicines for topical administration (see "allergic rhinitis").
Mistakes and unreasonable appointments
At uncomplicated acute and chronic infectious rhinitis purpose of antibacterial medicines is unreasonable. Because of the available complications topical administration of vasoconstrictive medicines at children till 2 flyings and patients with subatrophic and atrophic changes of a mucous membrane of a nose is limited.